文献速递产科母胎医学

顶级医学与妇产科期刊中产科随机对照试验的数量与质量分析

Number and quality of randomized controlled trials in obstetrics published in the top general medical and obstetrics and gynecology journals.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-10-14

本研究检索了2018至2020年9本顶级周刊医学期刊和妇产科期刊,共发现137项产科随机对照试验,其中24.1%发表于周刊医学期刊,75.9%发表于妇产科期刊。周刊医学期刊发表的试验样本量更大、更多接受政府资助、多中心、非美国基于和双盲设计,但两组在试验类型和质量指标上无差异。

要点

  • 顶级期刊每年约发表45项产科随机对照试验,其中四分之一在周刊医学期刊。
  • 仅约三分之一产科随机对照试验主要结局为阳性。
  • 周刊医学期刊试验样本量更大、更多政府资助、多中心、双盲,质量指标相似。

核心结论

  • 顶级期刊每年约发表45项产科随机对照试验,其中约四分之一发表于周刊医学期刊,其余发表于妇产科期刊。
  • 仅约三分之一的产科随机对照试验为阳性。
  • 周刊医学期刊发表的试验样本量更大、更多政府资助、多中心、国际化和双盲,但质量指标与妇产科期刊相似。

研究设计与样本

  • 研究检索了2019年影响因子最高的4本周刊医学期刊、4本顶级月度妇产科期刊和 American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine,纳入2018至2020年发表的产科随机对照试验。
  • 共纳入137项产科随机对照试验,其中2018年46项、2019年47项、2020年44项。

主要发现

  • 在9本期刊3年发表的4024篇原创研究中,1221篇(30.3%)为随机对照试验,其中137篇(11.2%)为产科随机对照试验。
  • 137项产科随机对照试验中,33项(24.1%)发表于周刊医学期刊,104项(75.9%)发表于妇产科期刊。
  • 各期刊发表的产科随机对照试验比例范围为1.5%至9.6%。
  • 总体34.3%的产科随机对照试验主要结局为统计学显著或阳性。
  • 24.8%的试验在首例患者入组后回顾性注册。

临床怎么用

  • 产科随机对照试验发表数量有限,临床医生应关注顶级期刊上发表的产科随机对照试验以获取高质量证据。
  • 周刊医学期刊发表的产科随机对照试验通常样本量更大、多中心、双盲且政府资助,可能更具普遍性,但质量指标与妇产科期刊相似。
  • 约四分之一产科随机对照试验在首例患者入组后回顾性注册,提示需关注试验注册的时效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been an increasing number of randomized controlled trials published in obstetrics and maternal-fetal medicine to reduce biases of treatment effect and to provide insights on the cause-effect of the relationship between treatment and outcomes. OBJECTIVE: This study aimed to identify obstetrical randomized controlled trials published in top weekly general medical journals and monthly obstetrics and gynecology journals, to assess their quality in reporting and identify factors associated with publication in different journals. STUDY DESIGN: The 4 weekly medical journals with the highest 2019 impact factor (New England Journal of Medicine, The Lancet, The Journal of the American Medical Association, and The BMJ), the top 4 monthly obstetrics and gynecology journals with obstetrics-related research (American Journal of Obstetrics & Gynecology, Ultrasound in Obstetrics & Gynecology, Obstetrics & Gynecology, and the BJOG: An International Journal of Obstetrics and Gynaecology), and the American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine were searched for obstetrical randomized controlled trials in the years 2018 to 2020. The primary outcome was the number of obstetrical randomized controlled trials published in the obstetrics and gynecology journals vs the weekly medical journals and the percentage of trials published, overall and per journal. The secondary outcomes included the proportion of positive vs negative trials overall and per journal and the assessment of the study characteristics of published trials, including quality assessment criteria. RESULTS: Of the 4024 original research articles published in the 9 journals during the 3-year study period, 1221 (30.3%) were randomized controlled trials, with 137 (11.2%) randomized controlled trials being in obstetrics (46 in 2018, 47 in 2019, and 44 studies in 2020). Furthermore, 33 (24.1%) were published in weekly medical journals, and 104 (75.9%) were published in obstetrics and gynecology journals. The percentage of obstetrical randomized controlled trials published ranged from 1.5% to 9.6% per journal. Overall, 34.3% of obstetrical trials were statistically significant or "positive" for the primary outcome. Notably, 24.8% of the trials were retrospectively registered after the enrollment of the first study patient. Trials published in the 4 weekly medical journals enrolled significantly more patients (1801 vs 180; P<.001), received more often funding from the federal government (78.8% vs 35.6%; P<.001), and were more likely to be multicenter (90.9% vs 42.3%; P<.001), non-United States based (69.7% vs 49.0%; P=.03), and double blinded (45.5% vs 18.3%; P=.003) than trials published in the obstetrics and gynecology journals. There was no difference in study type (noninferiority vs superiority) and trial quality characteristics, including pretrial registration, ethics approval statement, informed consent statement, and adherence to the Consolidated Standards of Reporting Trials guidelines statement between studies published in weekly medical journals and studies published in obstetrics and gynecology journals. CONCLUSION: Approximately 45 trials in obstetrics are being published every year in the highest impact journals, with one-fourth being in the weekly medical journals and the remainder in the obstetrics and gynecology journals. Only about a third of published obstetrical trials are positive. Trials published in weekly medical journals are larger, more likely to be funded by the government, multicenter, international, and double blinded. Quality metrics are similar between weekly medical journals and obstetrics and gynecology journals.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Doulaveris G, Vani K, Saccone G, et al. Number and quality of randomized controlled trials in obstetrics published in the top general medical and obstetrics and gynecology journals. Am J Obstet Gynecol MFM. 2021. PMID: 34656731. doi:10.1016/j.ajogmf.2021.100509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。